Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Mon, 17.11.2025
Lisata Therapeutics Inc
Company Name:
Lisata Therapeutics Inc
ISIN:
US1280583022
Reason for the research:
Update
Recommendation:
BUY
from:
17.11.2025
Target price:
USD 15
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on Lisata Therapeutics, Inc. (ISIN: [ … ]
Mon, 17.11.2025
Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG
Company Name:
Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG
ISIN:
DE0008041005
Reason for the research:
Update
Recommendation:
Buy
from:
17.11.2025
Target price:
EUR 1.10
Target price on sight of:
12-18 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research u [ … ]
Mon, 17.11.2025
INDUS Holding AG
Company Name:
INDUS Holding AG
ISIN:
DE0006200108
Reason for the research:
Update
Recommendation:
Buy
from:
17.11.2025
Target price:
35.00 Euro
Target price on sight of:
12 month
Last rating change:
none
Analyst:
Daniel Großjohann, Thomas Schießle
Q3: Adjusted EBITA exceeds market expectations, market environme [ … ]
Mon, 17.11.2025
PNE AG
Company Name:
PNE AG
ISIN:
DE000A0JBPG2
Reason for the research:
Update
Recommendation:
Buy
from:
17.11.2025
Target price:
19,00 Euro
Target price on sight of:
12 Monate
Last rating change:
02.02.2023: Hochstufung von Hinzufügen auf Kaufen
Analyst:
Dr. Karsten von Blumenthal
First Berlin Equity Research hat ein Research U [ … ]
Mon, 17.11.2025
Grand City Properties SA
Company Name:
Grand City Properties SA
ISIN:
LU0775917882
Reason for the research:
Neunmonatsbericht
Recommendation:
Kaufen
from:
17.11.2025
Target price:
€15
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu Grand City Properties S.A. ( [ … ]
Mon, 17.11.2025
Energiekontor AG
Company Name:
Energiekontor AG
ISIN:
DE0005313506
Reason for the research:
Update
Recommendation:
Buy
from:
17.11.2025
Target price:
93,00 Euro
Target price on sight of:
12 Monate
Last rating change:
18.10.2022: Hochstufung von Hinzufügen auf Kaufen
Analyst:
Dr. Karsten von Blumenthal
First Berlin Equity Research hat ein [ … ]
Mon, 17.11.2025
The Platform Group AG
Company Name:
The Platform Group AG
ISIN:
DE000A2QEFA1
Reason for the research:
Update
Recommendation:
Buy
from:
17.11.2025
Target price:
20,00 Euro
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Alexander Rihane
First Berlin Equity Research hat ein Research Update zu The Platform Group AG (ISIN: DE000A2QEF [ … ]
Mon, 17.11.2025
Semperit AG Holding
Company Name:
Semperit AG Holding
ISIN:
AT0000785555
Reason for the research:
Update
Recommendation:
Buy
from:
17.11.2025
Target price:
EUR 18.50
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Semperit delivered solid Q3 results. Here are the key takeaways:Q3 sales came in at € 163m, [ … ]
Mon, 17.11.2025
Rosenbauer International AG
Company Name:
Rosenbauer International AG
ISIN:
AT0000922554
Reason for the research:
Update
Recommendation:
Buy
from:
17.11.2025
Target price:
EUR 54.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
On Friday, Rosenbauer presented strong Q3 results. Here are the key takeaways:Q3 revenue [ … ]
Fri, 14.11.2025
Mister Spex SE
Company Name:
Mister Spex SE
ISIN:
DE000A3CSAE2
Reason for the research:
update
Recommendation:
Buy
from:
14.11.2025
Target price:
5.00
Last rating change:
Analyst:
Ralf Marinoni
FY 2025 guidance confirmedMister Spex continues its performance from earlier in the year into Q3: lower sales due to a reduction in discount campaigns [ … ]
